Home › Overweight › Alabama › Birmingham
Pag-aaral pangklinika para sa Overweight sa Birmingham, AL
16 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Birmingham (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Nagre-recruitPhase 3
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Nagre-recruitPhase 3
- University of Alabama at Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Nagre-recruitPhase 3
- Birmingham Clinical Research, Birmingham
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
Nagre-recruitPhase 3
- Central Alabama Research, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Nagre-recruitPhase 2
- University of Alabama - Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- ACCOMPLISH-2 Research Site, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Nagre-recruit
- University of Alabama at Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Nagre-recruitPhase 3
- Univ of Alabama Birmingham, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 3
- AURORA-1 Clinical Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Nagre-recruitPhase 3
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Nagre-recruitPhase 3
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
Nagre-recruit
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Nagre-recruit
- The Worship Center Cristian Church, Birmingham
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL29 pag-aaral
- Orlando, FL27 pag-aaral
- Dallas, TX23 pag-aaral
- Miami, FL23 pag-aaral
- Washington, DC20 pag-aaral
- Atlanta, GA20 pag-aaral
- Austin, TX19 pag-aaral
- Las Vegas, NV19 pag-aaral
- Jacksonville, FL19 pag-aaral
- New York City, NY19 pag-aaral
Iba pang pag-aaral sa Birmingham
- Kanser (lahat ng uri)30 pag-aaral
- Kanser sa Ovary25 pag-aaral
- Kanser sa Suso24 pag-aaral
- Non-Small Cell Lung Cancer23 pag-aaral
- Obesity22 pag-aaral
- Acute Myeloid Leukemia21 pag-aaral
- COPD17 pag-aaral
- Multiple Myeloma17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Type 2 Diabetes16 pag-aaral
- Cystic Fibrosis15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.